AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 291: H2660-H2668, 2006. First published September 1, 2006; doi:10.1152/ajpheart.00489.2006
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/6/H2660    most recent
00489.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huber, J. D.
Right arrow Articles by Houser, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huber, J. D.
Right arrow Articles by Houser, K. A.

Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats

Jason D. Huber, Reyna L. VanGilder, and Kimberly A. Houser

Department of Basic Pharmaceutical Sciences, West Virginia University, Morgantown, West Virginia

Submitted 12 May 2006 ; accepted in final form 24 August 2006

This study investigated the effects of streptozotocin-induced diabetes on the functional integrity of the blood-brain barrier in the rat at 7, 28, 56, and 90 days, using vascular space markers ranging in size from 342 to 65,000 Da. We also examined the effect of insulin treatment of diabetes on the formation and progression of cerebral microvascular damage and determined whether observed functional changes occurred globally throughout the brain or within specific brain regions. Results demonstrate that streptozotocin-induced diabetes produced a progressive increase in blood-brain barrier permeability to small molecules from 28 to 90 days and these changes in blood-brain barrier permeability were region specific, with the midbrain most susceptible to diabetes-induced microvascular damage. In addition, results showed that insulin treatment of diabetes attenuated blood-brain barrier disruption, especially during the first few weeks; however, as diabetes progressed, it was evident that microvascular damage occurred even when hyperglycemia was controlled. Overall, results of this study suggest that diabetes-induced perturbations to cerebral microvessels may disrupt homeostasis and contribute to long-term cognitive and functional deficits of the central nervous system.

in situ; endothelial; cerebral blood flow; neurovascular; dementia



Address for reprint requests and other correspondence: J. D. Huber, Dept. of Basic Pharmaceutical Sciences, West Virginia Univ. School of Pharmacy, PO Box 9530, Morgantown, WV 26506 (jhuber{at}hsc.wvu.edu)




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
T. A. Brooks, N. Nametz, R. Charles, and T. P. Davis
Diclofenac Attenuates the Regional Effect of {lambda}-Carrageenan on Blood-Brain Barrier Function and Cytoarchitecture
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 665 - 673.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. A. Banks
The dam breaks: disruption of the blood-brain barrier in diabetes mellitus
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2595 - H2596.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.